Affiliation:
1. Medical Department, SmithKline Beecham Pharmaceuticals, Madrid, Spain.
Abstract
Serum bactericidal activity against a penicillin-susceptible strain and a penicillin-resistant strain of Streptococcus pneumoniae (amoxicillin and cefotaxime MICs, 0.001 and 1 microg/ml, respectively, and MBCs, 0.01 and 2 microg/ml, respectively) was measured in 12 healthy volunteers who each received an oral 875-mg dose of amoxicillin and an intramuscular 1-g dose of cefotaxime in a crossover fashion. The areas under the bactericidal activity-time curves for the two strains were found to be similar for both antibiotics despite the significantly higher (P < 0.002) AUC/MIC and peak level/MIC values for cefotaxime.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference16 articles.
1. Altman D. G. 1991. Practical statistics for medical research p. 179-228. Chapman and Hall London United Kingdom.
2. Antimicrobial resistance in Streptococcus pneumoniae: an overview;Appelbaum P. C.;Clin. Infect. Dis.,1992
3. Prospective study on the etiology of community-acquired pneumonia in children and adults;Ausina V.;Spain. Eur. J. Clin. Microbiol. Infect. Dis.,1988
4. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation;Balcabao I. P.;Antimicrob. Agents Chemother.,1996
5. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects;Barriere S. L.;Antimicrob. Agents Chemother.,1985
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献